Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
Ekso Bionics Holdings (Nasdaq: EKSO), a leader in medical and industrial exoskeleton technology, has announced its participation in the 15th Annual Craig-Hallum Alpha Select Conference on November 19, 2024, in New York. CEO Scott Davis and CFO Jerome Wong will conduct one-on-one meetings with institutional investors during the event. Interested investors should contact their Craig-Hallum representative to schedule meetings.
Ekso Bionics Holdings (Nasdaq: EKSO), un leader nella tecnologia degli esoscheletri medici e industriali, ha annunciato la sua partecipazione alla 15ª Conferenza Annuale Craig-Hallum Alpha Select il 19 novembre 2024, a New York. Il CEO Scott Davis e il CFO Jerome Wong condurranno incontri one-to-one con investitori istituzionali durante l'evento. Gli investitori interessati possono contattare il loro rappresentante Craig-Hallum per pianificare gli incontri.
Ekso Bionics Holdings (Nasdaq: EKSO), un líder en tecnología de exoesqueletos médicos e industriales, ha anunciado su participación en la 15ª Conferencia Anual Craig-Hallum Alpha Select el 19 de noviembre de 2024, en Nueva York. El CEO Scott Davis y el CFO Jerome Wong llevarán a cabo reuniones uno a uno con inversores institucionales durante el evento. Los inversores interesados deben contactar a su representante de Craig-Hallum para programar reuniones.
엑스코 바이오닉스 홀딩스 (Nasdaq: EKSO), 의료 및 산업용 외골격 기술의 선두주자가 2024년 11월 19일 뉴욕에서 열리는 제15회 크레이그-할럼 알파 셀렉트 컨퍼런스에 참여한다고 발표했습니다. CEO 스코트 데이비스와 CFO 제롬 웡이 행사 중 기관 투자자와 일대일 회의를 진행할 예정입니다. 관심 있는 투자자는 회의 일정을 잡기 위해 크레이그-할럼 대표에게 문의해야 합니다.
Ekso Bionics Holdings (Nasdaq: EKSO), un leader dans la technologie des exosquelettes médicaux et industriels, a annoncé sa participation à la 15e Conférence Annuelle Craig-Hallum Alpha Select qui se tiendra le 19 novembre 2024 à New York. Le PDG Scott Davis et le CFO Jerome Wong organiseront des réunions individuelles avec des investisseurs institutionnels pendant l'événement. Les investisseurs intéressés doivent contacter leur représentant Craig-Hallum pour planifier des réunions.
Ekso Bionics Holdings (Nasdaq: EKSO), ein führendes Unternehmen in der Medizintechnik und industriellen Exoskelett-Technologie, hat seine Teilnahme an der 15. Jahrestagung der Craig-Hallum Alpha Select Conference am 19. November 2024 in New York bekannt gegeben. CEO Scott Davis und CFO Jerome Wong werden während der Veranstaltung Einzelgespräche mit institutionellen Investoren führen. Interessierte Investoren sollten sich an ihren Craig-Hallum-Vertreter wenden, um Meetings zu vereinbaren.
- None.
- None.
SAN RAFAEL, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Scott Davis, Chief Executive Officer, and Jerome Wong, Chief Financial Officer, will be participating at the 15th Annual Craig-Hallum Alpha Select Conference taking place in New York on Tuesday, November 19, 2024.
Management will be participating in one-on-one meetings with institutional investors throughout the conference. For those interested in a meeting, please contact your Craig-Hallum representative.
About Ekso Bionics®
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on X.
Contact:
David Carey
212-867-1768
investors@eksobionics.com
FAQ
When is Ekso Bionics (EKSO) participating in the Craig-Hallum Alpha Select Conference 2024?
Who will represent Ekso Bionics (EKSO) at the 2024 Craig-Hallum Conference?
What type of meetings will Ekso Bionics (EKSO) conduct at the Craig-Hallum Conference 2024?
How can investors meet with Ekso Bionics (EKSO) management at the Craig-Hallum Conference?
